Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MDGL · against 172 other Healthcare companies of similar size
Ranked #112 of 173 · scores higher than 35% of peers · safety percentile 33
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)15 peers with a safety percentile of 30–39, including MDGL · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MDGL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 168 reported | 0.66× | 0.33× | 32% | 33% | |
| BetaLower is better · 174 reported | -1.05 | 0.56 | 99% | 33% | |
| Current ratioHigher is better · 165 reported | 3.21× | 2.37× | 65% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 4.6B USD | 98 | 29 | |
| 108 | 52.2B HKD (≈$6.7B) | 34 | 56 | |
| 109 | 7.7B USD | 34 | 37 | |
| 110 | 47.8B HKD (≈$6.1B) | 34 | 60 | |
| 111 | 45.1B HKD (≈$5.8B) | 33 | 53 | |
| 112 | 9.2B USD | 33 | 39 | |
| 113 | 5.1B USD | 32 | 52 | |
| 114 | 1.21T INR (≈$14.6B) | 31 | 55 | |
| 115 | 4.4B CHF (≈$5.1B) | 31 | 47 | |
| 116 | 2.57T JPY (≈$17.5B) | 30 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score